University of Kentucky
Lexington, Kentucky, 40506, United States
NCT Number: NCT03248661
This study will randomly assign 220 men and women to either a social media intervention or a standard reminder system to have a repeat screening test for colo-rectal cancer.
Looking for future studies?
Notify Me30 year–75 year
All sexes
Interventional
Phase 3
Lexington, Kentucky, 40506, United States
Only persons initially screening by FIT (through a Rural Cancer Prevention Center service program) will be eligible for study participation. The objective is to test a social media-based intervention designed to promote annual repeat colo-rectal cancer screening using the Fecal Immunochemical Test (FIT) among person who have taken the FIT test once before. 220 men and women (50 to 75 years of age) will be recruited and randomly assigned to either the intervention condition (monthly social media contact) or a control condition (standard of care reminder for repeat testing one month before the annual test is due). The dependent variable will be whether volunteers requested and retuned a FIT kit with 60 days of the annual due date (one year from their initial screening).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Messages will be sent trough Facebook, Twitter, Instagram, e-mail, texting or other electronic/social media specified by study volunteers.
Time frame: 15 months
the endpoint is a received completed FIT kit
Richard Crosby
Other
Assessing Repeat Annual FIT Screening for Colo-Rectal Cancer (CRC)
Acronym: ARFT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07718919
Colo-rectal Cancer, Colonic Diseases
Cagliari, Italy
View Trial DetailsNCT05708950
Adnexal Diseases, Breast Cancer
Santa Monica, California, United States
View Trial DetailsNCT04223141
Colo-rectal Cancer, Colonic Diseases
Vejle, Denmark
View Trial DetailsNCT07517848
Colo-rectal Cancer, Colonic Diseases
Manisa, Turkey (Türkiye)
View Trial Details